New Ways of Thinking and Operating to Drive Business Value

07:30 - 08:30 Breakfast & Registration

08:30 - 08:45 Chairperson’s Opening Remarks

Hussain Mooraj, Principal at Deloitte

Hussain Mooraj

Principal
Deloitte

08:45 - 09:05 KEYNOTE: Supply Chain Control Towers to Enable Greater Visibility and Control of the Entire Supply Process

A control tower can act as an integrated command center that uses real-time information from existing, analytic systems to coordinate processes across the end-to-end supply chain and drive business value. Pfizer’s transportation control tower enables the company to monitor and measure the supply of a product, including the orders, and global shipments to determine trends in how the supply chain will react in the future.

A Supply Model Transformation (SMT) program helps manage the supply chain more effectively by having greater visibility and control of the entire supply process, from sourcing raw materials to delivery of products to customers and consumers.

This talk will discuss building a lasting supply chain control tower solution, and how an all-encompassing information resource has become such a critical aspect of the Pfizer global supply chain.
Jim Cafone, VP, Supply Operations at Pfizer

Jim Cafone

VP, Supply Operations
Pfizer

09:05 - 09:25 KEYNOTE: Unveiling the 8th Annual UPS Pain in the (Supply) Chain Survey

Regulatory Complexity? Temperature- Controlled Logistics? Winter Storms? What’s been your greatest 2015 pain in the chain? Whatever it is, you are not alone facing the challenge. In this talk, Robin Hooker, the Director of Marketing within the Healthcare Sector at UPS will provide insight around the challenges uncovered from the 2015 UPS Pain in the (Supply) Chain survey results as well as the solutions that best-in-class companies are using.
Robin Hooker, Director, Marketing, Healthcare Sector at UPS

Robin Hooker

Director, Marketing, Healthcare Sector
UPS

09:25 - 09:45 KEYNOTE: Voice-of-the- Customer: How Life Science Organizations can Become more Customer-Centric

Healthcare systems are transforming. Fee-for-service is slowly becoming phased-out as pay-for-performance methodology takes center-stage. The traditional ways health systems manage the healthcare supply chain is also changing by the extension to the patient’s bedside improving patient care and saving lives. These changes impact the quality of the care provided as physicians and nurses are freed up to spend more time on clinical decision making and less on ancillary supply chain activities. This session will guide manufacturers to the following:
  • What provider networks and hospital systems need from industry to operationally align
  • Using the supply chain to drive the best possible care to patients within the new pay-for-performance model
  • How to best engage with customers to improve supply chain processes
Vance Moore, Senior Vice President of Operations at Mercy

Vance Moore

Senior Vice President of Operations
Mercy

09:45 - 10:15 Morning Networking Break

This discussion between the key stakeholders across the supply chain will discuss the current challenges facing successful industry collaboration:
  • The mental model and availability of talent within respective organizations to handle today’s operational model
  • Disparate metrics and the incentives in place to drive successful collaboration – how are industry goals different then customer utilization goals?
  • How can supply chain collaboration drive efficiency by limiting sales and marketing spend to the docs/ physicians/specialists
  • What are some of the unique ways different stakeholders are collaborating together to optimize supply chain value?
Vance Moore, Senior Vice President of Operations at Mercy

Vance Moore

Senior Vice President of Operations
Mercy

Kevin Cook, VP, Supply Chain, Demand Mgmt. & Customer Service NA at Sandoz

Kevin Cook

VP, Supply Chain, Demand Mgmt. & Customer Service NA
Sandoz

Hussain Mooraj, Principal at Deloitte

Hussain Mooraj

Principal
Deloitte

Joe Short

Senior Vice President of Operations
AmerisourceBergen

11:00 - 11:20 Keynote: Serialization, Global Networking and the Internet of Things for Life Sciences

Today’s pharmaceutical supply chain is at a tipping point. Emerging track and trace regulations are driving the reorganization of supply chain business processes and the infrastructure required to support them. Implementing serialization across global operations calls for new thinking about platforms that can not only deliver massive data and transaction processing elasticity, but achieve network connectivity that securely links businesses together to collaborate and advance the value of the pharmaceutical supply chain ecosystem as a whole while enabling more intimate connections with the patient. More than ever, it’s critical that today’s investments in compliance solutions provide the foundation for necessary future market insight and business connectivity that supports the fast approaching intersection of the Internet of Things and the Life Sciences industry.
This talk will highlight both the vision and platform requirements for a globally connected supply network from ingredient to patient. It will highlight unique opportunities associated with connecting multiple enterprises to achieve complex compliance initiatives on a global scale; gain insights from sharing and analyzing respective business data sets; and drive collective operational efficiencies for the entire Life Sciences industry.

Shabbir Dahod, President and CEO at TraceLink

Shabbir Dahod

President and CEO
TraceLink

11:20 - 11:30 Benchmarking Survey


11:30 - 11:45 Short Break

Workshop A

11:45 - 13:00 Networking Team Activity – Work Alongside other Attendees and Test Your Supply Chain Coordination Capabilities at the LogiPharma Supply Chain “Beer Game”
From CEOs to high-school students, the MIT Supply Chain Beer Game is used regularly to teach the principles of supply chain coordination that remain so critical in today’s super-connected, electronic-datainterchange focused, ERP/MRPcontrolled world.

Work alongside your fellow attendees to fix typical supply chain problems during this interactive role-playing supply chain simulation. The aim is for each group to fulfil incoming orders of beer by placing orders with the next upstream party. At the end, hear from your peers on the bottlenecks that were encountered and why they occurred.
WIll Millhiser, Associate Professor of Management at Baruch

WIll Millhiser

Associate Professor of Management
Baruch

Workshop B

11:45 - 13:00 Networking Team Activity – Analyzing Group Decision Making after Supply Chain Disruption


Luncheon

13:00 - 14:15 For All Attendees

Private Luncheon

13:00 - 14:15 Hosted by Accenture

Track A: Security and Risk-Mitigation

14:15 - 14:25 Chairperson’s Opening Remarks

Track B: Taking a Holistic Approach to Serialization

14:15 - 14:25 Chairperson’s Opening Remarks

Track A: Security and Risk-Mitigation

14:25 - 14:45 Understanding In-house Security Dangers
As industry refines security and risk mitigation strategies to limit outside interference, the often overlooked “softspot” can be a companies internal security as most breaches are orchestrated from an internal resource.

In this unique session, Steve Lubeski will discuss the efforts taken at Alexion to ensure this risk-factor is managed and through a case study involving outside parnerships, will provide your organization with takeaways and considerations for what you can do to also secure your internal risks.

Steven Lubeski

Senior Manager, Global Security
Alexion Pharmaceuticals

Track B: Taking a Holistic Approach to Serialization

14:25 - 14:45 A Practical Approach to Serialization - What is Needed to be Done before 2017
Priya Gopal, Associate Director, Strategic Planning & Projects at Novartis

Priya Gopal

Associate Director, Strategic Planning & Projects
Novartis

Track A: Security and Risk-Mitigation

14:45 - 15:05 Understanding In-house Security Dangers cont.



Steven Lubeski

Senior Manager, Global Security
Alexion Pharmaceuticals

Track B: Taking a Holistic Approach to Serialization

14:45 - 15:05 Advocating for Common Sense Serialization Requirements Around the Globe
Brian Tarantino, Lead, Global Product Serialization at Merck & Co.

Brian Tarantino

Lead, Global Product Serialization
Merck & Co.

Track A: Security and Risk-Mitigation

15:05 - 15:25 Continuity and Crisis Management: How Important are they when Facing Supply Chain Disruptions?

Track B: Taking a Holistic Approach to Serialization

15:05 - 15:25 With the Regulations in Place, How Manufacturers can use Serialization as a Value-Add for the Business
Meeting Global Serialization Regulatory Mandates remain a top priority for Manufacturers. The question is how do companies look beyond just compliance to utilize the technology and functionality for other business gains? Industry has to become compliant and needs to find a silver lining. There are major business opportunities from serializing products, including:
  • Inventory accountability
  • Forecasting and supply demand balancing
  • Commercial management of new product sales and reorders
  • Improved productivity in the warehouse with order fulfillment and data accuracy
  • Identifying sources of product diversion in their supply chain and more targeted product incident reporting

This session will closely examine the business benefits of serialization and how organizations can better leverage their serialization solutions.

Pari Sanghavi, Sr. Director, Supply Chain & Manufacturing at Cognizant Life Sciences

Pari Sanghavi

Sr. Director, Supply Chain & Manufacturing
Cognizant Life Sciences

Track A: Security and Risk-Mitigation

15:25 - 16:05 PANEL DISCUSSION: How Industry is Securing Both In-Transit and Storage of Pharmaceutical Goods
The World Health Organization estimates that approximately 1% of medicines available in the developed world are likely to be fraudulent. Based on this estimate, of the approximately 4 billion prescriptions written in the United States in 2011, 40 million of those were likely to have been fraudulent. As long as there’s money to made counterfeiting pharmaceuticals, criminals will evolve and continue to attempt to do so. This panel will address the following:
  • Current best practices for securing the pharma supply chain
  • Updates on global regulatory supply chain integrity and steps taken with agencies to ensure integrity throughout the entire pharma lifecycle
  • Technology innovations and the future of supply chain security

Brad Elrod, Director, Global Conveyance Security at Pfizer

Brad Elrod

Director, Global Conveyance Security
Pfizer

Jim Yarbrough, Global Intelligence Program Manager at BSI Supply Chain Solutions

Jim Yarbrough

Global Intelligence Program Manager
BSI Supply Chain Solutions

David Wadsworth

Global Logistics Consultant
Eli Lilly & Co.

Track B: Taking a Holistic Approach to Serialization

15:25 - 16:05 PANEL DISCUSSION: Achieving True Interoperability by Sharing Transaction Information with Trading Partners
One of the biggest challenges of creating a secure supply chain network is synchronizing inventory and money transfer between network partners. This panel will discuss how different stakeholders within the supply chain can share data and create true business intelligence through interoperability.
  • How business is intelligence can be gained through shared data
  • How lost revenue due to diversion can be recovered through shared data
  • The current hurdles in the way of achieving this transparency
Priya Gopal, Associate Director, Strategic Planning & Projects at Novartis

Priya Gopal

Associate Director, Strategic Planning & Projects
Novartis

Miguel Pitarch, Executive Director Global Serialization, BMS at Bristol-Myers Squibb

Miguel Pitarch

Executive Director Global Serialization, BMS
Bristol-Myers Squibb

Ron Guido, CEO at ExxPharma Therapeutics

Ron Guido

CEO
ExxPharma Therapeutics

16:05 - 16:45 Afternoon Networking and Refreshment Break


1. The Total Cost of Loss
Henry Ames, General Manager, Sensitech Life Sciences

2. Managing Complex Procurement Challenges
Mitchel Syp, Vice President Country Head of Industry Vertical Healthcare, USA Panalpina, Inc.

3. The Certified Cargo Screening Program
Thomas Friedman, Industry Engagement Manager, Surface Air Cargo TSA

4. Beyond "Lessons Learned" - Surprising Serialization Benefits and Challenges Uncovered
Lisa Hamlin, Associate Director, Information Technology - Serialization, Allergan

5. Product Launches and Speed to Market
S. Greg Magnusen, Senior Director, Global Supply Chain, Eli Lilly and Company

6. The Weak Links in the Data Chain
Stephen Winyard, Pharma Cold Chain Industry Expert, Envirotainer

7. Myths and Reality on Total Landed Costs (TLC)
Camille Madelon, Director, Strategy and Business Development, Envirotainer

Thomas Friedman, Industry Engagement Manager, Surface Air Cargo at Transportation Security Administration

Thomas Friedman

Industry Engagement Manager, Surface Air Cargo
Transportation Security Administration

Greg Magnusen, Senior Director - Global Supply Chain at Eli Lilly and Company

Greg Magnusen

Senior Director - Global Supply Chain
Eli Lilly and Company

Henry Ames, General Manager at Sensitech Life Sciences

Henry Ames

General Manager
Sensitech Life Sciences

Mitchel Syp, Vice President Country Head of Industry Vertical Healthcare, USA at Panalpina, Inc.

Mitchel Syp

Vice President Country Head of Industry Vertical Healthcare, USA
Panalpina, Inc.

Steve Winyard

Pharma Cold Chain Industry Expert - Americas
Envirotainer

Camille Madelon, Director, Strategy and Business Development at Envirotainer

Camille Madelon

Director, Strategy and Business Development
Envirotainer

17:45 - 18:30 Craft Beer and Wine Tasting Cocktail Reception

18:30 - 23:59 Close of Day One